Efficacy and safety of repetitive transcranial magnetic stimulation for generalised anxiety disorder: A meta-analysis - PubMed (original) (raw)

Efficacy and safety of repetitive transcranial magnetic stimulation for generalised anxiety disorder: A meta-analysis

Huiru Cui et al. Gen Psychiatr. 2019.

Abstract

Background: Pharmacological and conventional non-pharmacological treatments are only moderately effective in treating generalised anxiety disorder (GAD). Recently, repetitive transcranial magnetic stimulation (rTMS) has attracted interest because of its potential therapeutic value.

Aim: To investigate the efficacy and safety of rTMS treatment for GAD.

Methods: Literature studies published in English or Chinese were screened in 10 electronic databases up to 5 December 2018. The included studies' bias risk was assessed using Cochrane risk of bias assessment tool. Meta-analysis was performed to compute the standardised mean difference (SMD) and risk ratio (RR) along with its 95% CIs through using RevMan V.5.3. Heterogeneity was inspected by I2 and the χ2 test. We performed subgroup analysis and meta-regression to investigate heterogeneity. We used funnel plot to assess publication bias. We used the GRADE approach to assess the whole quality of evidence.

Results: Twenty-one studies, with a total sample size of 1481, were analysed. The risk of bias in most studies included is moderate, the majority of which are lacking of blinding methods of treatment allocation. The treatment had beneficial effects in the rTMS group compared with the control group in mean anxiety score (SMD=-0.68; 95% CI -0.89 to -0.46). None of the 21 studies included here reported severe adverse events. As for dropout rates, there are no statistically significant differences between the two groups (RR 1.14, 95% CI 0.72 to 1.82) or adverse events (RR 0.95, 95% CI 0.77 to 1.18). No particular influence on the heterogeneity of any variable was observed. The risk of publication bias was low. According to the GRADE approach, the evidence levels of primary outcome (treatment effects) and secondary outcomes (acceptability and safety) were rated as 'medium'.

Conclusion: The use of rTMS combined with medication treatment may have a significant positive anti-anxiety effect on patients with GAD. However, we should interpret the results cautiously due to the relatively high heterogeneity of the meta-analysis. Future high-quality clinical trials are needed to confirm our results.

Keywords: anxiety; generalized anxiety disorder; meta-analysis; repetitive transcranial magnetic stimulation; rtms.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1

Figure 1

Flowchart of the literature screening.

Figure 2

Figure 2

Risk of bias graph: in the form of percentage of each bias risk in all included studies.

Figure 3

Figure 3

Funnel plot to assess potential publication bias in 21 included studies. SMD, standardised mean difference.

Figure 4

Figure 4

Forest plot illustrating efficacy of repetitive transcranial magnetic stimulation group compared with control group in the treatment of generalised anxiety disorder. Random-effects models were used.

Figure 5

Figure 5

Forest plot illustrating acceptability of repetitive transcranial magnetic stimulation group compared with control group in the treatment of generalised anxiety disorder. Fixed-effects models were used.

Figure 6

Figure 6

Forest plot illustrating adverse effects of repetitive transcranial magnetic stimulation group compared with control group in treating generalised anxiety disorder. Fixed-effects models were used.

Figure 7

Figure 7

Forest plot of subgroup analysis illustrating efficacy of repetitive transcranial magnetic stimulation group compared with control group in treating generalised anxiety disorder: left hemisphere vs right hemisphere. Random-effects models were used.

Figure 8

Figure 8

Forest plot of subgroup analysis illustrating efficacy of repetitive transcranial magnetic stimulation group compared with control group in treating generalised anxiety disorder: high frequency stimulation vs low frequency stimulation. Random-effects models were used.

Figure 9

Figure 9

Forest plot of subgroup analysis illustrating efficacy of repetitive transcranial magnetic stimulation group compared with control group in treating generalised anxiety disorder: treatment regimen ≤20 times vs treatment regimen >20 times. Random-effects models were used.

References

    1. Cui H, Zhang J, Liu Y, et al. Differential alterations of resting-state functional connectivity in generalized anxiety disorder and panic disorder. Hum Brain Mapp 2016;37:1459–73. 10.1002/hbm.23113 -DOI -PMC -PubMed
    1. Hu Q, Wan Y, Su L, et al. Prevalence of anxiety disorder among mainland residents in China: a meta-analysis. Chin J Psychiatry 2013;46:204–11.
    1. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci 2017;19:93–107. -PMC -PubMed
    1. Ströhle A, Gensichen J, Domschke K. The diagnosis and treatment of anxiety disorders. Dtsch Arztebl Int 2018;155:611–20. 10.3238/arztebl.2018.0611 -DOI -PMC -PubMed
    1. Patterson B, Van Ameringen M. Augmentation strategies for treatment-resistant anxiety disorders: a systematic review and meta-analysis. Depress Anxiety 2016;33:728–36. 10.1002/da.22525 -DOI -PubMed

LinkOut - more resources